(lp0
S'3 Questions Synergy Pharmaceuticals Inc  Stock Owners Need Answered BNL Finance    - 7 hours ago Liam Hunter is a former sell side biotech analyst on Wall Street, and from his previous research, he likes the direction of Synergy Pharmaceuticals Inc  and the upside of SGYP stock long-term. Hunter has been cautiously optimistic, and ...Synergy Pharma  Submits sNDA for TRULANCE to Treat IBS-C - StreetInsider.comAnalyst: Synergy Pharma Could Achieve Sustainable Profitability By 2018 - Benzinga'
p1
aS"Revenue Approximations Analysis: Southwestern Energy Company , Synergy ... StockNewsJournal - 20 hours ago Synergy Pharmaceuticals Inc. , maintained return on investment for the last twelve months at -253.37, higher than what Reuters data shows regarding industry's average."
p2
aS'Synergy Pharmaceuticals Inc.  And Its Technical Chart Creates A ... NY Stock News - 16 hours ago Synergy Pharmaceuticals Inc.  has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.'
p3
aS"Canaccord Chimes in on Synergy Pharmaceuticals Inc  as It Prepares for ... Smarter Analyst - Mar 2, 2017 Yesterday, Synergy Pharmaceuticals Inc  reported fourth-quarter financial results and reiterated the launch of Trulance , Synergy's recently-approved lead drug, for treatment of chronic idiopathic constipation , which is&nbsp;...Synergy Pharmaceuticals Inc.  Soars 7.83% on February 27 - Equities.comSynergy Pharmaceuticals  Getting Ready for Trulance Launch - Economic Calendar"
p4
aS'Synergy Pharmaceuticals Inc.  Is Rising But Watch The Charts And Be Careful USA Commerce Daily - 13 hours ago With all other things going on, Synergy Pharmaceuticals Inc.  has been on a run - rising 0.84 percent in just three months.'
p5
aS'Synergy Pharmaceuticals Inc  Releases Q4 and Full-Year Financial Results Smarter Analyst - Mar 1, 2017 Synergy Pharmaceuticals Inc  reported its financial results and business update for the full year and the three months ended December 31, 2016.'
p6
aS"Synergy's Trulance Looking Like The Next Uceris Seeking Alpha - Mar 13, 2017 Synergy Pharmaceuticals , a gastrointestinal company out of New York, was recently approved for their drug Trulance.Synergy Pharmaceuticals: Approval, Now What? - Bloomington Pantagraph"
p7
aS'Synergy Pharmaceuticals Inc.  Plunges 8.64% on March 21 Equities.com - Mar 21, 2017 Synergy Pharmaceuticals Inc.  had a rough trading day for Tuesday March 21 as shares tumbled 8.64%, or a loss of $-0.44 per share, to close at $4.65.'
p8
aS"Synergy Pharmaceuticals to Present at Oppenheimer 27th Annual Healthcare ... Yahoo Finance - Mar 14, 2017 Synergy Pharmaceuticals Inc.  today announced that Marino Garcia, the company's EVP and Chief Strategy Officer, will present a corporate update at the Oppenheimer 27th Annual Healthcare Conference on Tuesday, March 21, 2017 at 11:30 a.m.&nbsp;..."
p9
aS'Buy/Sell Signals for Synergy Pharmaceuticals Inc.  and Rocket Fuel Inc ... USA Commerce Daily - Mar 27, 2017 Shares of Synergy Pharmaceuticals Inc.  are making a strong comeback as they have jumped 79.92% since bottoming out at $2.6 on Mar. 29, 2016.'
p10
a.